Edition:
United States

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

11.48USD
1:32pm EDT
Change (% chg)

$0.61 (+5.61%)
Prev Close
$10.87
Open
$10.91
Day's High
$11.59
Day's Low
$10.89
Volume
74,050
Avg. Vol
71,052
52-wk High
$20.73
52-wk Low
$5.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.77 December 20 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 4 4
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.43
Year Ending Dec-19 5 0.00 0.00 0.00 3.10
Earnings (per share)
Quarter Ending Jun-18 6 -0.77 -0.69 -0.96 -0.69
Quarter Ending Sep-18 6 -0.76 -0.59 -0.96 -0.72
Year Ending Dec-18 6 -3.14 -2.78 -3.57 -2.73
Year Ending Dec-19 5 -3.01 -2.36 -4.34 -2.69

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.03 0.00 0.03 100.00
Quarter Ending Jun-17 0.05 0.00 0.05 100.00
Quarter Ending Mar-17 0.08 0.00 0.08 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.43
Year Ending Dec-19 0.00 0.00 0.00 0.00 3.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings